EXPLORE!

Low dose Rituximab

  802 Views

Dr SG Parasramani, Mumbai    23 January 2019

  • There is no consensus on the dose of rituximab to be used, the interval between infusions, and need for repeat infusions.
  • The use of rituximab is an evolving work in progress.
  • Available data has limitations but the drug is effective.
  • Whether this control is long term, or of limited duration is not known.
  • A protocol that is unique for autoimmune mucocutaneous blistering disease is needed.
  • Rituximab in low dose is the new frontier for the treatment of pemphigus.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.